Skip to content

Atherosclerotic Plaque Characterization

Atherosclerotic Plaque Characterization Using Multispectral, Multicontrast High Resolution Cardiovascular Magnetic Resonance Imaging

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00861653
Acronym
APC
Enrollment
50
Registered
2009-03-13
Start date
2006-10-31
Completion date
2013-07-31
Last updated
2014-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Keywords

Atherosclerosis, Subjects diagnosed with atherosclerosis

Brief summary

The purpose of this study is to utilize high-resolution CMR carotid imaging for the characterization of carotid wall volumes and plaque content in patients with clinical significant carotid atherosclerosis. Patients who are scheduled to undergo an imaging procedure will be recruited from the cath lab. Upon enrollment, blood samples conventional and genetic profiling will be collected. For patients undergoing a carotid endarterectomy, tissue from the carotid vessel will be collected during their procedure. Comparison of the MR images with tissue and/or blood samples will be made. Length of time in the study will be approximately 1 day. There will be no study-related patient follow-up.

Interventions

None listed

Sponsors

Piedmont Healthcare
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age range \>17 years of age * Surgical carotid artery disease * Provide written informed consent and Authorization for Use/Disclosure of PHI

Exclusion criteria

* History of carotid trauma * History of middle or large vessel vasculitis * Refusal to provide written informed consent and Authorization for * Use/Disclosure of PHI

Design outcomes

Primary

MeasureTime frame
Characterization of plaque that is found in the carotid walls of patients who have atherosclerosis2 years post study initiation

Secondary

MeasureTime frame
To evaluate the effectiveness of MR imaging in identifying these plaque characteristics2 Years Post Study Initiation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026